ArticleInternational journal of molecular sciences2026
Last Licensed Non-Classical Peptide Presenter HLA-F: Its Occurrence, Immunoediting Significance, and Possible Therapeutic Implications in Renal Cell Carcinoma.
Libuše Janků et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.